GB910456A - Therapeutic compositions comprising a penicillin antibiotic and sulphonamides - Google Patents
Therapeutic compositions comprising a penicillin antibiotic and sulphonamidesInfo
- Publication number
- GB910456A GB910456A GB2967961A GB2967961A GB910456A GB 910456 A GB910456 A GB 910456A GB 2967961 A GB2967961 A GB 2967961A GB 2967961 A GB2967961 A GB 2967961A GB 910456 A GB910456 A GB 910456A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphonamides
- therapeutic compositions
- mgm
- penicillin antibiotic
- penicillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Orally administrable compositions for the treatment of bacterial infections comprise per unit dose from 120 to 280 mgm. of potassium phenoxyethyl penicillin and from 130 to 200 mgm of each of sulphadiazine, sulphamerazine and sulphamethazine. They may be in forms such as a tablet or flavoured aqueous suspension which may optionally also comprise tetracycline, bismuth subcarbonate and pyridium in addition to conventional pharmaceutical excipients.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5363860A | 1960-09-02 | 1960-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB910456A true GB910456A (en) | 1962-11-14 |
Family
ID=21985596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2967961A Expired GB910456A (en) | 1960-09-02 | 1961-08-17 | Therapeutic compositions comprising a penicillin antibiotic and sulphonamides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB910456A (en) |
-
1961
- 1961-08-17 GB GB2967961A patent/GB910456A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA71221B (en) | New pharmaceutical compositions for the treatment of microbial infections | |
GB910456A (en) | Therapeutic compositions comprising a penicillin antibiotic and sulphonamides | |
DE3260277D1 (en) | Peptide antibiotic, component b, process for its preparation and its use in medicines | |
ES442505A1 (en) | Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions | |
SE8404556D0 (en) | PHARMACEUTICAL COMPOSITION | |
ES365212A1 (en) | Substituted glyoxal dithiosemicarbazones | |
FR2307542A1 (en) | Immuno-stimulant preparations for human and veterinary use - contg. a mixture of inactivated and lysed bacterial cells | |
AU460683B2 (en) | New pharmaceutical compositions for the treatment of microbial infections | |
GB1299037A (en) | Dithiocarbamic acid esters | |
GB2009154A (en) | Antibacterial compounds | |
GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
AU2425571A (en) | New pharmaceutical compositions for the treatment of microbial infections | |
ES383595A1 (en) | Improvements in pharmaceutical compositions | |
FR1489M (en) | 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases. | |
FR3392M (en) | Dermatological medicinal product, in particular for the treatment of oozing eczema. | |
FR2510M (en) | New medicament usable for the treatment of staphylococcal infections and the like. | |
GB976096A (en) | Pharmaceutical compositions | |
AU232392B2 (en) | Pharmaceutical compositions for bacterial and/or fungal infections ofman and animals | |
CA859699A (en) | Medicine for treatment of infections | |
FR363M (en) | New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections. | |
AU4628459A (en) | Pharmaceutical compositions for bacterial and/or fungal infections ofman and animals | |
FR385M (en) | New drug for the treatment of staphylococcal infections and the like. | |
GB824011A (en) | Pharmaceutical compositions containing 1-methyl-6-nitro-4-quinolone-3-carboxylic acid | |
IT1247695B (en) | Calcitonin-based pharmaceutical compositions administrable by the nasal route in human therapy | |
GB709088A (en) | Anti-bacterial therapeutic preparations containing penicillin |